Literature DB >> 24526870

Stiripentol for dravet syndrome: is it worth it?

Eric Kossoff.   

Abstract

Entities:  

Year:  2014        PMID： 24526870      PMCID： PMC3913306          DOI： 10.5698/1535-7597-14.1.22

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  8 in total

1.  In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.

Authors:  Carole Giraud; Jean-Marc Treluyer; Elisabeth Rey; Catherine Chiron; Jean Vincent; Gérard Pons; Agnès Tran
Journal:  Drug Metab Dispos       Date:  2006-01-13       Impact factor: 3.922

Review 2.  The ketogenic diet in Dravet syndrome.

Authors:  Linda Laux; Robyn Blackford
Journal:  J Child Neurol       Date:  2013-05-07       Impact factor: 1.987

Review 3.  Diagnosis and long-term course of Dravet syndrome.

Authors:  Ingrid E Scheffer
Journal:  Eur J Paediatr Neurol       Date:  2012-06-16       Impact factor: 3.140

Review 4.  The pharmacologic treatment of Dravet syndrome.

Authors:  Catherine Chiron; Olivier Dulac
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

5.  Dravet syndrome and parent associations: the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief.

Authors:  Joan V Skluzacek; Kathryn P Watts; Olivier Parsy; Beverly Wical; Peter Camfield
Journal:  Epilepsia       Date:  2011-04       Impact factor: 5.864

6.  Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group.

Authors:  C Chiron; M C Marchand; A Tran; E Rey; P d'Athis; J Vincent; O Dulac; G Pons
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

7.  Pharmacokinetics of stiripentol in normal man: evidence of nonlinearity.

Authors:  R H Levy; H S Lin; H M Blehaut; J A Tor
Journal:  J Clin Pharmacol       Date:  1983 Nov-Dec       Impact factor: 3.126

8.  Stiripentol open study in Japanese patients with Dravet syndrome.

Authors:  Yushi Inoue; Yoko Ohtsuka; Hirokazu Oguni; Jun Tohyama; Hiroshi Baba; Katsuyuki Fukushima; Hideyuki Ohtani; Yukitoshi Takahashi; Shunya Ikeda
Journal:  Epilepsia       Date:  2009-06-22       Impact factor: 5.864
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.